TP53 and cancer: On the other hand, previous literatures have linked mutation in the tumor suppressor gene TP53 with activation of proteasome subunits for adaptation to proteotoxic stress and evasion of apoptosis in cancer cells [7], leading to the idea that targeting proteasome pathway may be a potential treatment strategy for tumors harboring p-53 mutation.